Skip to content
The Nexus
DossierENTITY

PhRMA

Coverage of PhRMA in the Nexus archive.

Earliest in view: May 13 · 20:45 UTCMost recent: Jul 27 · 18:13 UTC
Co-mentioned in this coverage
pharmaceutical industrytopic1drug spendingtopic1lobbyingtopic1Cassidyperson1CDCorganization1autism websitetopic1GOPorganization1Planned Parenthoodorganization1Steve Ublperson1Bristol Myers Squibborganization1Chris Boernerperson1Food and Drug Administrationorganization1Marty Makaryperson1Kyle Diamantasperson1
Recent coverage
  • HEALTHJul 27 · 18:13 UTCSTAT NEWS
    STAT+: Pharma’s drug spending deflection

    The pharmaceutical industry's lobbying group, PhRMA, is attempting to deflect attention from rising prescription drug spending by sending news releases and talking points to journalists. The article highlights PhRMA's efforts to influence reporting on drug spending trends.

  • HEALTHJul 23 · 23:04 UTCTHE HILL
    Cassidy cites autism website change in support of CDC nominee

    Cassidy supports a CDC nominee by referencing a change in an autism-related website. The article is presented by PhRMA.

  • POLITICSJul 21 · 23:02 UTCTHE HILL
    GOP bill leaves out anti-Planned Parenthood language

    A GOP bill omitted anti-Planned Parenthood language. The bill was presented by PhRMA.

  • HEALTHMay 13 · 20:45 UTCAXIOS
    Pharma leaders hope next FDA head calms waters

    The pharmaceutical industry is calling for stability and predictability from the next FDA commissioner after a tumultuous period. The CEO of PhRMA, Steve Ubl, and Bristol Myers Squibb CEO Chris Boerner emphasized the need for a stable FDA to ensure certainty in drug development. The industry is also pushing back against President Trump's 'most favored nation' pricing policy.